AB 2340,
as amended, Garcia. begin deleteState Department of Public Health: Office of Health Equity. end deletebegin insertMedi-Cal: benefits: clinic costs for drugs and supplies.end insert
Existing law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid Program provisions. Existing law provides for a department-administered uniform schedule of health care benefits. Existing law sets the cost that specified clinics bill the Medi-Cal program and the Family PACT Waiver Program for drugs and supplies at an aggregate amount equivalent to the sum of the actual acquisition cost of a drug or supply plus a clinic dispensing fee not to exceed $12 per billing unit, as specified. Existing law sets the cost for a take-home drug that is dispensed for use by the patient within a specific timeframe of 5 or less days from the date medically indicated at the actual acquisition cost for that drug plus a clinic dispensing fee, not to exceed $17 per prescription. Existing law sets the reimbursement at the lesser of the amount billed or the Medi-Cal reimbursement rate and caps reimbursement at the net cost of these drugs or supplies when provided by retail pharmacies under the Medi-Cal program.
end insertbegin insertThis bill would remove the cap on the dispensing fees. The bill would require the clinic dispensing fee to be the difference between the actual acquisition cost of a drug or supply, to be calculated not less than annually, and the Medi-Cal reimbursement rate. The bill would also remove the cap on reimbursement that is based on the cost of drugs or supplies provided by retail pharmacies.
end insertExisting law requires the State Department of Public Health to establish an Office of Health Equity, led by the Deputy Director of the Office of Health Equity, for the purposes of aligning state resources, decisionmaking, and programs to accomplish various goals, including improving the health status of all populations and places, with a priority on eliminating health and mental health disparities and inequities. Existing law requires the office to establish an advisory committee, as specified, to advance the goals of the office and to actively participate in decisionmaking.
end deleteThis bill would authorize the deputy director to include on the advisory committee representatives from women’s health organizations that focus on health disparities and inequalities related to gender.
end deleteVote: majority.
Appropriation: no.
Fiscal committee: begin deleteno end deletebegin insertyesend insert.
State-mandated local program: no.
The people of the State of California do enact as follows:
begin insertSection 14132.01 of the end insertbegin insertWelfare and Institutions
2Codeend insertbegin insert is amended to read:end insert
(a) Notwithstanding any other provision of law, a
4community clinic or free clinic licensed pursuant to subdivision
5(a) of Section 1204 of the Health and Safety Code or an intermittent
6clinic operating pursuant to subdivision (h) of Section 1206 of the
7Health and Safety Code, that has a valid license pursuant to Article
813 (commencing with Section 4180) of Chapter 9 of Division 2
9of the Business and Professions Code shall bill and be reimbursed,
10as described in this section, for drugs and supplies covered under
11the Medi-Cal program and Family PACT Waiver Program.
12(b) (1) A clinic described in subdivision (a) shall bill the
13Medi-Cal program and Family PACT Waiver Program for drugs
P3 1and supplies covered
under those programs at the lesser of cost or
2the clinic’s usual charge made to the general public.
3(2) For purposes of this section, “cost” means an aggregate
4amount equivalent to the sum of the actual acquisition cost of a
5drug or supply plus a clinic dispensingbegin delete fee not to exceed twelve
6dollars ($12) per billing unit as identified in either the Family
7PACT Policies, Procedures, and Billing Instructions Manual, or
8the Medi-Cal Inpatient/Outpatient Provider Manual governing
9outpatient clinic billing for drugs and supplies, as applicable. For
10purposes of this section, “cost” for a take-home drug that is
11dispensed for use by the patient within a specific timeframe of five
12or less days from the
date medically indicated means actual
13acquisition cost for that drug plus a clinic dispensing fee, not to
14exceed seventeen dollars ($17) per prescription. Reimbursement
15shall be at the lesser of the amount billed or the Medi-Cal
16reimbursement rate, and shall not exceed the net cost of these drugs
17or supplies when provided by retail pharmacies under the Medi-Cal
18program.end delete
19be calculated not less than annually. The clinic dispensing fee
20shall be the difference between the actual acquisition cost of a
21drug or supply and the Medi-Cal reimbursement rate.end insert
22(c) Reimbursement shall be at the lesser of the amount billed
23or the Medi-Cal reimbursement rate.
24(c)
end delete
25begin insert(d)end insert A clinic described in subdivision (a) that furnishes services
26free of charge, or at a nominal charge, as defined in subsection (a)
27of Section 413.13 of Title 42 of the Code of Federal Regulations,
28or that can demonstrate to the department, upon request, that it
29serves primarily low-income patients, and its customary practice
30is to charge patients on the basis of their ability to pay, shall not
31be subject to reimbursement reductions based on its usual charge
32to the general public.
33(d)
end delete
34begin insert(e)end insert Federally
qualified health centers and rural health clinics
35that are clinics as described in subdivision (a) may bill and be
36reimbursed as described in this section, upon electing to be
37reimbursed for pharmaceutical goods and services on a
38fee-for-service basis, as permitted by subdivision (k) of Section
3914132.100.
40(e)
end delete
P4 1begin insert(f)end insert A clinic that otherwise meets the qualifications set forth in
2subdivision (a), that is eligible to, but that has elected not to, utilize
3drugs purchased under the 340B Discount Drug Program for its
4Medi-Cal patients, shall provide notification to the Health
5Resources and Services Administration’s Office of Pharmacy
6Affairs that it is utilizing non-340B drugs for its
Medi-Cal patients
7in the manner and to the extent required by federal law.
All matter omitted in this version of the bill appears in the bill as amended in the Assembly, March 28, 2014 . (JR11)
O
97